Vault-13

First Light Asset Management, LLC

Edina, MN · CIK 1600004 · 13F filing filed 2026-08-14

SEC-registered investment adviser since 2013 · limited liability company

$1.6bn reported value +47.4% vs Q1 2026
31positions
60.7%in top 10
2 new 17 added 12 reduced 6 sold out vs Q1 2026

Holdings, Q2 2026

The small lines show how much was held over the last 4 quarters (adjusted for stock splits).

#SecurityTickerShares Value% of portfolioChangeShares change
1 NEOGENOMICS INC COM NEW NEO NEO 12,279,523 $179.2m10.89% 10.89% AddedShares held: Q3 2025 9.9m, Q4 2025 10.0m, Q1 2026 9.7m, Q2 2026 12.3m +2.5m +2,549,545 26.2%
2 SI-BONE INC COM SIBN SIBN 8,127,985 $132.6m8.06% 8.06% AddedShares held: Q3 2025 1.9m, Q4 2025 5.0m, Q1 2026 5.4m, Q2 2026 8.1m +2.8m +2,774,795 51.8%
3 AXOGEN INC COM AXGN AXGN 2,748,361 $126.9m7.72% 7.72% ReducedShares held: Q3 2025 5.8m, Q4 2025 5.2m, Q1 2026 4.0m, Q2 2026 2.7m -1.3m -1,254,407 -31.3%
4 APOGEE THERAPEUTICS INC COM COM 930,289 $123.5m7.50% 7.50% AddedShares held: Q3 2025 0, Q4 2025 285.0k, Q1 2026 576.7k, Q2 2026 930.3k +353.6k +353,605 61.3%
5 PALVELLA THERAPEUTICS INC NE COM PVLA PVLA 771,901 $118.0m7.17% 7.17% ReducedShares held: Q3 2025 541.5k, Q4 2025 709.1k, Q1 2026 980.8k, Q2 2026 771.9k -208.9k -208,857 -21.3%
6 TWIST BIOSCIENCE CORP COM TWST TWST 727,933 $74.9m4.55% 4.55% ReducedShares held: Q3 2025 1.2m, Q4 2025 1.1m, Q1 2026 878.8k, Q2 2026 727.9k -150.9k -150,915 -17.2%
7 ENLIVEN THERAPEUTICS INC COM ELVN ELVN 1,360,750 $69.1m4.20% 4.20% AddedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 201.9k, Q2 2026 1.4m +1.2m +1,158,883 574.1%
8 GUARDANT HEALTH INC COM GH GH 441,586 $66.3m4.03% 4.03% AddedShares held: Q3 2025 280.0k, Q4 2025 294.8k, Q1 2026 280.3k, Q2 2026 441.6k +161.3k +161,287 57.5%
9 908 DEVICES INC COM MASS MASS 6,282,804 $54.7m3.32% 3.32% AddedShares held: Q3 2025 2.5m, Q4 2025 4.8m, Q1 2026 6.1m, Q2 2026 6.3m +210.2k +210,241 3.5%
10 AMYLYX PHARMACEUTICALS INC COM AMLX AMLX 3,023,256 $54.3m3.30% 3.30% ReducedShares held: Q3 2025 3.4m, Q4 2025 3.4m, Q1 2026 3.2m, Q2 2026 3.0m -167.4k -167,389 -5.2%
11 GENEDX HOLDINGS CORP COM CL A WGS WGS 783,923 $53.8m3.27% 3.27% AddedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 242.9k, Q2 2026 783.9k +541.0k +540,996 222.7%
12 SIMULATIONS PLUS INC COM COM 2,792,677 $51.1m3.11% 3.11% AddedShares held: Q3 2025 767.8k, Q4 2025 2.0m, Q1 2026 2.6m, Q2 2026 2.8m +159.9k +159,854 6.1%
13 TANDEM DIABETES CARE INC COM NEW TNDM TNDM 3,383,553 $51.1m3.10% 3.10% AddedShares held: Q3 2025 0, Q4 2025 1.1m, Q1 2026 1.3m, Q2 2026 3.4m +2.1m +2,068,838 157.4%
14 CRINETICS PHARMACEUTICALS IN COM CRNX CRNX 1,360,866 $50.9m3.10% 3.10% AddedShares held: Q3 2025 941.5k, Q4 2025 1.2m, Q1 2026 1.1m, Q2 2026 1.4m +271.2k +271,196 24.9%
15 NEUROPACE INC COM NPCE NPCE 2,861,167 $45.5m2.76% 2.76% AddedShares held: Q3 2025 1.4m, Q4 2025 1.3m, Q1 2026 2.5m, Q2 2026 2.9m +401.2k +401,201 16.3%
16 EDGEWISE THERAPEUTICS INC COM EWTX EWTX 1,095,171 $44.5m2.70% 2.70% AddedShares held: Q3 2025 1.4m, Q4 2025 1.6m, Q1 2026 1.0m, Q2 2026 1.1m +93.3k +93,325 9.3%
17 ANAPTYSBIO INC COM ANAB ANAB 582,004 $39.3m2.39% 2.39% AddedShares held: Q3 2025 990.2k, Q4 2025 646.2k, Q1 2026 565.4k, Q2 2026 582.0k +16.6k +16,573 2.9%
18 TREVI THERAPEUTICS INC COM TRVI TRVI 2,097,215 $39.1m2.38% 2.38% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 2.1m
19 SEPTERNA INC COM SEPN SEPN 963,260 $32.3m1.96% 1.96% AddedShares held: Q3 2025 0, Q4 2025 620.8k, Q1 2026 732.9k, Q2 2026 963.3k +230.4k +230,400 31.4%
20 TRISALUS LIFE SCIENCES INC COM TLSI TLSI 6,552,491 $29.8m1.81% 1.81% AddedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 5.1m, Q2 2026 6.6m +1.5m +1,485,664 29.3%
21 TECTONIC THERAPEUTIC INC COM TECX TECX 800,726 $27.5m1.67% 1.67% AddedShares held: Q3 2025 202.4k, Q4 2025 0, Q1 2026 647.7k, Q2 2026 800.7k +153.0k +152,983 23.6%
22 HEALTH CATALYST INC COM HCAT HCAT 12,810,861 $25.5m1.55% 1.55% ReducedShares held: Q3 2025 13.4m, Q4 2025 12.9m, Q1 2026 12.9m, Q2 2026 12.8m -67.8k -67,839 -0.5%
23 BUTTERFLY NETWORK INC COM CL A BFLY BFLY 2,642,404 $22.2m1.35% 1.35% ReducedShares held: Q3 2025 1.1m, Q4 2025 2.8m, Q1 2026 2.7m, Q2 2026 2.6m -17.8k -17,763 -0.7%
24 ESTABLISHMENT LABS HLDGS INC COM ESTA ESTA 246,577 $21.2m1.29% 1.29% ReducedShares held: Q3 2025 418.4k, Q4 2025 373.1k, Q1 2026 307.7k, Q2 2026 246.6k -61.2k -61,161 -19.9%
25 VAXCYTE INC COM PCVX PCVX 345,157 $20.1m1.22% 1.22% AddedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 141.8k, Q2 2026 345.2k +203.4k +203,373 143.4%
26 IRHYTHM TECHNOLOGIES INC COM IRTC IRTC 167,092 $19.9m1.21% 1.21% ReducedShares held: Q3 2025 155.1k, Q4 2025 153.9k, Q1 2026 168.1k, Q2 2026 167.1k -1.0k -1,024 -0.6%
27 OMNICELL COM COM OMCL OMCL 452,324 $18.8m1.14% 1.14% ReducedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 489.8k, Q2 2026 452.3k -37.5k -37,522 -7.7%
28 ATRICURE INC COM ATRC ATRC 567,838 $15.9m0.97% 0.97% ReducedShares held: Q3 2025 890.4k, Q4 2025 1.2m, Q1 2026 729.5k, Q2 2026 567.8k -161.7k -161,683 -22.2%
29 KORU MEDICAL SYSTEMS INC COM KRMD KRMD 3,387,902 $14.2m0.86% 0.86% ReducedShares held: Q3 2025 4.5m, Q4 2025 4.2m, Q1 2026 3.8m, Q2 2026 3.4m -380.5k -380,478 -10.1%
30 TACTILE SYS TECHNOLOGY INC COM TCMD TCMD 462,562 $13.8m0.84% 0.84% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 462.6k
31 RHYTHM PHARMACEUTICALS INC COM RYTM RYTM 85,765 $9.5m0.58% 0.58% ReducedShares held: Q3 2025 180.5k, Q4 2025 295.8k, Q1 2026 87.2k, Q2 2026 85.8k -1.4k -1,416 -1.6%

Sold out since Q1 2026

SecurityTickerShares held beforeValue then
CENTESSA PHARMACEUTICALS PLC 1,560,991 $62.0m1.6m shares
WAVE LIFE SCIENCES LTD 96663EUR 96663EUR 1,843,968 $13.4m1.8m shares
VERA THERAPEUTICS INC VERA VERA 313,906 $12.6m313.9k shares
MIMEDX GROUP INC MDXG MDXG 2,842,892 $11.2m2.8m shares
SPYGLASS PHARMA INC SGP SGP 375,000 $9.7m375.0k shares
ORGANOGENESIS HLDGS INC ORGO ORGO 3,498,533 $8.3m3.5m shares

Stakes above 5%

Companies where this manager has reported owning more than 5% of a class of shares, on Schedule 13D (may seek influence) or 13G (passive): its latest filing for each, from 19 Dec 2024 on.

CompanyTickerStakeChange ScheduleLast filed
SI-BONE INC SIBN · 13G · filed 2026-05-07 SIBN 18.4%≈ $132.5m +6.4 pts 13G 2026-05-07
HEALTH CATALYST INC HCAT · 13D · filed 2026-03-13 HCAT 18.3%≈ $26.8m -1.4 pts 13D 2026-03-13
908 DEVICES INC MASS · 13G · filed 2026-02-17 MASS 17.1%≈ $53.8m +4.2 pts 13G 2026-02-17
PERFORMANT HEALTHCARE INC PFMT · 13G · filed 2025-08-14 PFMT 16.4% 13G 2025-08-14
SIMULATIONS PLUS INC 13G · filed 2026-02-06 13.2%≈ $48.5m new 13G 2026-02-06
NEUROPACE INC NPCE · 13G · filed 2026-09-04 NPCE 12.2%≈ $66.8m +3.6 pts 13G 2026-09-04
TRISALUS LIFE SCIENCES INC TLSI · 13G · filed 2026-07-07 TLSI 10.7%≈ $30.0m +2.0 pts 13G 2026-07-07
NEOGENOMICS INC NEO · 13G · filed 2026-08-14 NEO 8.4%≈ $157.0m -2.5 pts 13G 2026-08-14
KORU MEDICAL SYSTEMS INC KRMD · 13G · filed 2026-02-17 KRMD 8.3%≈ $16.1m -2.2 pts 13G 2026-02-17
AXOGEN INC AXGN · 13G · filed 2026-08-14 AXGN 7.6%≈ $188.1m +0.8 pts 13G 2026-08-14
PALVELLA THERAPEUTICS INC NE PVLA · 13G · filed 2026-08-14 PVLA 5.3%≈ $117.5m -2.2 pts 13G 2026-08-14